Outcomes of low-dose infliximab as an adjunctive therapy in patients with severe central nervous system tuberculosis

Outcomes of low-dose infliximab as an adjunctive therapy in patients with severe central nervous system tuberculosis

Introduction: High-dose (10mg/kg) infliximab is an effective and safe adjunctive option for severely ill and disabled patients with central nervous system tuberculosis (CNS TB). This has been planned for evaluation in clinical trials; however, the high cost of infliximab is a major concern in develo...

Full description

Saved in:
Bibliographic Details
Main Authors: Dr Selwyn Selvakumar, Dr Nishi Somarkutty, Dr Jayavelu Hariram Prasad, Dr Priyanka Gautam, Dr Prabhakar Thirumal Appaswamy, Dr Naveen Cherian Thomas, Dr Joy Sarojini Michael, Dr Rajiv Karthik, Dr George M Varghese, Dr Abi Manesh
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971224007562
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S1201971224007562

Similar Items